Skip to content
Homepage
Category:
Business
Posted Date:
June 5, 2026
TELESIN Launches Master Lens Series: Elevating iPhone 17 Pro & Pro Max Mobile Cinematography
Written By: EIN Presswire
June 5, 2026
KwickPOS and Samsung Electronics America Collaborate to Transform Mobile Payments for Restaurants
Written By: EIN Presswire
June 5, 2026
Tiller-Hewitt HealthCare Strategies Celebrates 25 Years of Helping Healthcare Organizations Achieve Strategic Growth
Written By: EIN Presswire
June 5, 2026
Outdoor Kitchens Continue to Grow in Popularity as Backyard Improvement Projects
Written By: EIN Presswire
June 5, 2026
International Spiritual Leader NOCCI Introduces the NOCCI Transformation Method
Written By: EIN Presswire
June 5, 2026
KenWorks Discusses How Gemologists Evaluate Diamonds and Precious Stones
Written By: EIN Presswire
June 5, 2026
SHARE3DCAM Launches AI Engine Algorithm Upgrade in SHARE PointClouds Studio V2.5.0, Advancing the Complete Scan-to-Deliverable Workflow for AEC and Renovation Professionals
SHARE3DCAM
June 5, 2026
Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control
Ractigen Therapeutics
June 5, 2026
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Bluejay Diagnostics, Inc.
June 5, 2026
OrsoBio to Present Preclinical and Clinical Data from its Mitochondrial Protonophore Portfolio at the American Diabetes Association’s 2026 Scientific Sessions
Business Wire
June 5, 2026
Tidepool Showcases New Real-World Clinical Data and Landmark Women’s Health Initiative at ADA 2026
Business Wire
June 5, 2026
How Custom Home Builders in Eden Prairie, MN Adapt to Lot Scarcity
PressAdvantage
June 5, 2026
CueCue Launches Interactive Web Card to Help People Earn From Skills, Services and Idle Assets
PR Underground
June 5, 2026
Verdiva Bio Presents Preclinical Data on Investigational Obesity Drug Candidates at the American Diabetes Association 86th Scientific Sessions
Business Wire
June 5, 2026
All-Round for Work & Play: KTC Dual-Mode Monitor H27P6 Adapts to Full-Scenario Needs
KTC TECHNOLOGY (HONGKONG) CO., LIMITED
June 5, 2026
Why you need independent energy this summer and beyond
Edgenewswire
June 5, 2026
NatureU® Now Has Three Clinical Studies Publicly Registered on ClinicalTrials.gov as 56-Day PQQ Skin-Aging Study (NCT07571629) Joins Two Previously Published Peer-Reviewed Trials
NatureU®
June 5, 2026
Fragrance Creators Association Makes History at the White House, Advancing the $80 Billion Case for Responsible Innovation to Senior Executive Branch Officials
Fragrance Creators Association
June 5, 2026
Procore and OneNotary Bring Credentialed Notarization Directly Into Construction Payments
Written By: EIN Presswire
June 5, 2026
Pahrump Brothel Adds Bitcoin and Ethereum Payment Options
PR Quantum
June 5, 2026
What Adults Should Know About Monitoring Blood Pressure Between Checkups
Written By: EIN Presswire
June 5, 2026
AI Straight Talk on TV Show from ‘Hands-On-Keyboard’ Engineer
Written By: EIN Presswire
June 5, 2026
Aqualia refuerza su liderazgo en innovación hídrica durante la IWA Leading Edge Conference 2026 en Houston
Written By: EIN Presswire
June 5, 2026
Coming Soon: Dr. Angel A. Diaz’s New Book Explains the Hidden War for Innovation, Security, and Power
Written By: EIN Presswire
June 5, 2026
What Travelers Should Know About Transportation Between Airports, Hotels, and Cruise Terminals
Written By: EIN Presswire
June 5, 2026
Hyperbaric Chamber Nashville: How HBOT, IV Therapy, and EBO2 Support Personalized Recovery Protocols
Written By: EIN Presswire
June 5, 2026
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study
Biomea Fusion, Inc.
June 5, 2026
DentaQuest Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
Edelson Lechtzin LLP
June 5, 2026
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
Kailera Therapeutics, Inc.
June 5, 2026
Oban BioPharma Announces Presentation of Late-Breaking Abstract at ADA 2026 Highlighting OBT-676: A First-in-Class Small Molecule Combining Dual Amylin and Calcitonin Receptor Full Agonism (DACRA) with GLP-1, GIP and Glucagon (Triple-G) Receptor Partial Agonism
Oban BioPharma, Inc.
June 5, 2026
Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
S&P Dow Jones Indices
June 5, 2026
Novo Nordisk’s investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes–presented at ADA 2026
NOVO NORDISK INC.
June 5, 2026
Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
AMERICAN DIABETES ASSOCIATION
June 5, 2026
Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate
Ambrosia Biosciences
June 5, 2026
Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial
Precision Diabetes, Inc.
June 5, 2026
Prev
1
…
1,309
1,310
1,311
